The developments at Holland Capital in 2024 reflect our strong ambitions
Amsterdam/ Düsseldorf, 30th of December 2024 –The developments at Holland Capital in 2024 reflect our strong ambitions. Guided by a focused investment strategy, we continued to actively engage in the high-growth markets of Technology, Healthcare, and Agrifood. Reflecting on a successful year, we completed several key transactions and further strengthened our team.
2024 achievements
- The launch of our fund, Holland Capital Growth and Buy-Out Fund V
- Number of deals in the Netherlands: 5
- Number of add-on acquisitions in the Netherlands: 13
- Number of add-on acquisitions in Germany: 2
- Number of exits: 2
- Number of new colleagues: 4
Sector focus and an entrepreneurial hands-on approach: With specialized sector teams, we focus on the sectors of Healthcare, Technology, and Agrifood, both within the Growth & Buy-out and Venture & Growth segments. We understand the dynamics and opportunities in these sectors and have an extensive network. Holland Capital is not a passive investor; we work closely with management to define and execute strategies. Where needed, our operational team also contributes hands-on to the realization of specific projects within the company.
Which companies would we like to connect with?
- Sector: Technology, Healthcare, and Agrifood
- Positive outlook: Significant growth potential, both autonomous and buy-and-build
- Growth & Buy-out:
- Healthy profitability: cash flow from operations (EBITDA) between EUR 1 – 10m
- Smaller companies: considered as add-on acquisitions for our existing portfolio companies
- Larger companies: considered together with a co-investor
- Venture & Growth:
- Start-ups and scale-ups: EBITDA EUR <1m
- Cash flow negative (in an accelerated growth scenario)
- Revenue EUR 0 – 5m
What to expect from us?
- Flexible approach to transaction structures: We strive to adapt each structure to the needs of the company and its shareholders. Depending on the type of investment, Holland Capital either provides growth capital and/or acquires existing shares. We are flexible regarding the final capital structure: both majority and minority stakes are possible.
- Deal certainty and an efficient process: Thanks to our sector expertise, we are able to quickly assess a business model and put a fair price on the table. Since the partnership with the entrepreneur and/or the management team is the cornerstone of our investment, we devote above-average attention to ensuring the process is completed efficiently, in the right spirit, and with mutual respect for both parties.
- Transparency towards advisors: We appreciate it when advisors involve us early in discussions with entrepreneurs and/or management teams. In such cases, we always ensure that the advisor’s interests are well safeguarded throughout the process. The advisor retains the flexibility to decide whether to represent the sell-side or buy-side in a potential transaction.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare, Technology, and Agrifood-Tech sector.
Our participation CytoSmart has been designated by Microsoft as a promising AI and cloud computing scale-up
Amsterdam, 16th of January 2019 – Our participation CytoSmart has been designated by Microsoft as a promising AI and cloud computing scale-up. Nine Dutch startups are joining Microsoft’s virtual ScaleUp program. The participating startups are developing solutions for...
Onze deelneming CytoSmart is door Microsoft aangewezen als veelbelovende AI en cloud-computing scale-up
Amsterdam, 16 januari 2019 - Onze deelneming CytoSmart is door Microsoft aangewezen als veelbelovende AI en cloud-computing scale-up. Negen Nederlandse startups nemen deel aan het virtuele ScaleUp-programma van Microsoft. De deelnemende startups ontwikkelen...
Holland Venture continues as Holland Capital
The experienced and hands-on investor in Healthcare and Technology Amsterdam, 10 January 2019 – As of today, Holland Venture will continue as Holland Capital. The new name reflects the current positioning of the investor; with various funds, Holland Capital invests in...
Holland Venture gaat verder als Holland Capital
De ervaren en hands-on investeerder in Healthcare en Technology Amsterdam, 10 januari 2019 – Vanaf heden gaat Holland Venture verder onder de naam Holland Capital. De nieuwe naam weerspiegelt de bestaande positionering van de investeerder; Holland Capital investeert...
Avensus Group expands its cloud activities by acquiring Client ICT
Amsterdam, 17th of December 2018 – Avensus Group acquires IT services company Client ICT. Client ICT focuses on midcap organisations with projects and managed services. This fits seamlessly in the ambitious buy-and-build strategy that Avensus, with the support of...
Avensus Groep breidt cloud activiteiten uit met overname Cliënt ICT
Amsterdam, 17 december 2018 – Avensus Groep neemt IT-dienstverlener Cliënt ICT over. Cliënt ICT richt zich met projecten en managed services op middelgrote organisaties. Dit past perfect in de ambitieuze buy-and-build strategie die Avensus, met steun van investeerder...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl